Rich May congratulates its client, Hamilton Thorne, Ltd., on its recent acquisition of Gynemed GmbH & Co. KG, a leading manufacturer and distributor of consumables and equipment for the in vitro fertilization clinic and laboratory markets for a total consideration of €13.9 million (approximately US$15.1 million).
About Hamilton Thorne Ltd.
Hamilton Thorne designs, manufactures and distributes precision laser devices and advanced imaging systems that reduce cost, increase productivity, improve results and enable breakthroughs in assisted reproductive technologies (ART) and developmental biology research markets. Hamilton Thorne’s laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and IVF procedures. Its imaging systems improve outcomes in human IVF clinics and animal breeding facilities and provide high-end toxicology analyses. Hamilton Thorne’s growing worldwide customer base consists of pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, animal breeding companies, and other commercial and academic research establishments, including Harvard, MIT, Yale, McGill, Oxford, Cambridge, the Smithsonian Institution, Charles River Labs, Covance, ABS Global, Sexing Technologies, Merck, Novartis, Pfizer, and Dow Chemical.
About Gynemed GmbH & Co. KG
Gynemed GmbH & Co. KG is a leading manufacturer and distributor of products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics. Gynemed offers a complete range of cell culture media for the embryology and andrology laboratory in the ART clinic. Founded in 1998, Gynemed has, since inception, demonstrated a commitment to quality products and services in Germany, Austria and Switzerland and is expanding across other European markets and internationally.